PH19670A - Substituted isoquinoline derivatives - Google Patents

Substituted isoquinoline derivatives

Info

Publication number
PH19670A
PH19670A PH30693A PH30693A PH19670A PH 19670 A PH19670 A PH 19670A PH 30693 A PH30693 A PH 30693A PH 30693 A PH30693 A PH 30693A PH 19670 A PH19670 A PH 19670A
Authority
PH
Philippines
Prior art keywords
image
isoquinoline derivatives
substituted isoquinoline
formula
substituted
Prior art date
Application number
PH30693A
Other languages
English (en)
Inventor
Hans Dr Bruderer
Richrad Wightman Kierstead
John G Mullin
Jr Jay Philip O'brien
Sideny Teitel
Keiji Nakamura
Mitsuru Tateishi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH19670A publication Critical patent/PH19670A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PH30693A 1983-05-19 1984-05-18 Substituted isoquinoline derivatives PH19670A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/496,327 US4544657A (en) 1983-05-19 1983-05-19 Substituted isoquinolines

Publications (1)

Publication Number Publication Date
PH19670A true PH19670A (en) 1986-06-09

Family

ID=23972146

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30693A PH19670A (en) 1983-05-19 1984-05-18 Substituted isoquinoline derivatives

Country Status (20)

Country Link
US (1) US4544657A (fr)
EP (1) EP0126480B1 (fr)
JP (1) JPS59222478A (fr)
KR (1) KR840009102A (fr)
AT (1) ATE32072T1 (fr)
AU (1) AU570044B2 (fr)
CA (1) CA1243028A (fr)
DE (1) DE3468875D1 (fr)
DK (1) DK248484A (fr)
ES (1) ES532603A0 (fr)
FI (1) FI81795C (fr)
GR (1) GR82015B (fr)
HU (1) HU192555B (fr)
IL (1) IL71860A (fr)
MC (1) MC1597A1 (fr)
NO (1) NO159271C (fr)
NZ (1) NZ208186A (fr)
PH (1) PH19670A (fr)
PT (1) PT78618A (fr)
ZA (1) ZA843748B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124511C1 (ru) * 1993-05-14 1999-01-10 Фармасьютикал Ко., Лтд Производные пиперазина
US5681954A (en) * 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
FR2840896B1 (fr) * 2002-06-18 2005-04-08 Sanofi Synthelabo Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant
EP2392571A3 (fr) 2005-07-29 2012-03-14 F. Hoffmann-La Roche AG Dérivés d'indol-3-yl-carbonyl-pipéridine et pipérazine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759443A (fr) * 1970-09-15 1971-04-30 I F L O Istituto Farmacologico Nouveau derive papaverolinique et procede de preparation relatif
DE2818423A1 (de) * 1978-04-27 1979-11-08 Hoechst Ag Neue isochinolinderivate und verfahren zu ihrer herstellung
IN154317B (fr) * 1979-07-19 1984-10-13 Andre Buzas
DE3034001A1 (de) * 1980-09-10 1982-04-22 Hoechst Ag, 6000 Frankfurt Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung

Also Published As

Publication number Publication date
NO159271C (no) 1988-12-14
ES8601141A1 (es) 1985-11-01
ATE32072T1 (de) 1988-02-15
PT78618A (en) 1984-06-01
AU570044B2 (en) 1988-03-03
FI841992A (fi) 1984-11-20
ES532603A0 (es) 1985-11-01
HUT34185A (en) 1985-02-28
ZA843748B (en) 1985-01-30
FI81795B (fi) 1990-08-31
DK248484D0 (da) 1984-05-17
IL71860A0 (en) 1984-09-30
FI81795C (fi) 1990-12-10
AU2835684A (en) 1984-11-22
CA1243028A (fr) 1988-10-11
US4544657A (en) 1985-10-01
FI841992A0 (fi) 1984-05-17
KR840009102A (ko) 1984-12-24
NO842003L (no) 1984-11-20
HU192555B (en) 1987-06-29
GR82015B (fr) 1984-12-12
MC1597A1 (fr) 1985-05-09
DE3468875D1 (en) 1988-02-25
DK248484A (da) 1984-11-20
JPS59222478A (ja) 1984-12-14
EP0126480A1 (fr) 1984-11-28
EP0126480B1 (fr) 1988-01-20
NO159271B (no) 1988-09-05
NZ208186A (en) 1987-06-30
IL71860A (en) 1987-10-30

Similar Documents

Publication Publication Date Title
CA2038848A1 (fr) Derives de l'hydantoine
AU591640B2 (en) Quinolonecarboxylic acid derivatives
NO170330C (no) Fremgangsmaate for fremstilling av vesentlig optisk rent monohydrat av s-(-)-propyl-2',6'-pipekoloksylididhydroklorid
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
ES8601201A1 (es) Procedimiento para preparar derivados de imidazolina
GR3003079T3 (en) Six-membered heterocyclic derivatives of n'substituted-n,n'-diacylhydrazines
PH19670A (en) Substituted isoquinoline derivatives
EP0285284A3 (en) N-phenethylaminoalkyl-benzamide anti-arrhythmia agents
DE3477380D1 (en) Novel benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions
DE3361789D1 (en) Cephalosporin derivatives, their preparation and medicaments containing them
AR243159A1 (es) Procedimiento de preparacion de acido 1-(3-mercapto-(2s)-metilpropionil)-pirrolidin-(2s)-carboxilico o sus sales farmaceuticamente aceptables.
AU553351B2 (en) Organophosphate derivatives
ES8603903A1 (es) Un procedimiento para preparar monosales y disales de fosfo-nicina con imidazol y-o sus derivados
BE902911A (fr) Derives n-imidazolyliques et leur preparation
JO1229B1 (en) Penicillin derivatives